165 related articles for article (PubMed ID: 32240735)
1. The status of the terminal regions of α-synuclein in different forms of aggregates during fibrillization.
Marvian AT; Aliakbari F; Mohammad-Beigi H; Ahmadi ZA; Mehrpooyan S; Lermyte F; Nasouti M; Collingwood JF; Otzen DE; Morshedi D
Int J Biol Macromol; 2020 Jul; 155():543-550. PubMed ID: 32240735
[TBL] [Abstract][Full Text] [Related]
2. The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes.
Lorenzen N; Lemminger L; Pedersen JN; Nielsen SB; Otzen DE
FEBS Lett; 2014 Jan; 588(3):497-502. PubMed ID: 24374342
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the dynamics of α-synuclein oligomers using hydrogen/deuterium exchange monitored by mass spectrometry.
Mysling S; Betzer C; Jensen PH; Jorgensen TJ
Biochemistry; 2013 Dec; 52(51):9097-103. PubMed ID: 24191706
[TBL] [Abstract][Full Text] [Related]
4. High stability and cooperative unfolding of α-synuclein oligomers.
Paslawski W; Andreasen M; Nielsen SB; Lorenzen N; Thomsen K; Kaspersen JD; Pedersen JS; Otzen DE
Biochemistry; 2014 Oct; 53(39):6252-63. PubMed ID: 25216651
[TBL] [Abstract][Full Text] [Related]
5. Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State.
Kurnik M; Sahin C; Andersen CB; Lorenzen N; Giehm L; Mohammad-Beigi H; Jessen CM; Pedersen JS; Christiansen G; Petersen SV; Staal R; Krishnamurthy G; Pitts K; Reinhart PH; Mulder FAA; Mente S; Hirst WD; Otzen DE
Cell Chem Biol; 2018 Nov; 25(11):1389-1402.e9. PubMed ID: 30197194
[TBL] [Abstract][Full Text] [Related]
6. How epigallocatechin gallate binds and assembles oligomeric forms of human alpha-synuclein.
Andersen CB; Yoshimura Y; Nielsen J; Otzen DE; Mulder FAA
J Biol Chem; 2021; 296():100788. PubMed ID: 34019875
[TBL] [Abstract][Full Text] [Related]
7. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.
Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT
Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954
[TBL] [Abstract][Full Text] [Related]
8. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization.
Ruggeri FS; Adamcik J; Jeong JS; Lashuel HA; Mezzenga R; Dietler G
Angew Chem Int Ed Engl; 2015 Feb; 54(8):2462-6. PubMed ID: 25588987
[TBL] [Abstract][Full Text] [Related]
9. SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway.
Giehm L; Oliveira CL; Christiansen G; Pedersen JS; Otzen DE
J Mol Biol; 2010 Aug; 401(1):115-33. PubMed ID: 20540950
[TBL] [Abstract][Full Text] [Related]
10. Oleuropein derivatives from olive fruit extracts reduce α-synuclein fibrillation and oligomer toxicity.
Mohammad-Beigi H; Aliakbari F; Sahin C; Lomax C; Tawfike A; Schafer NP; Amiri-Nowdijeh A; Eskandari H; Møller IM; Hosseini-Mazinani M; Christiansen G; Ward JL; Morshedi D; Otzen DE
J Biol Chem; 2019 Mar; 294(11):4215-4232. PubMed ID: 30655291
[TBL] [Abstract][Full Text] [Related]
11. The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's Disease.
Aliakbari F; Mohammad-Beigi H; Rezaei-Ghaleh N; Becker S; Dehghani Esmatabad F; Eslampanah Seyedi HA; Bardania H; Tayaranian Marvian A; Collingwood JF; Christiansen G; Zweckstetter M; Otzen DE; Morshedi D
Nanoscale; 2018 May; 10(19):9174-9185. PubMed ID: 29725687
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein.
Gallea JI; Celej MS
J Biol Chem; 2014 Sep; 289(39):26733-26742. PubMed ID: 25143382
[TBL] [Abstract][Full Text] [Related]
13. Structures of the E46K mutant-type α-synuclein protein and impact of E46K mutation on the structures of the wild-type α-synuclein protein.
Wise-Scira O; Dunn A; Aloglu AK; Sakallioglu IT; Coskuner O
ACS Chem Neurosci; 2013 Mar; 4(3):498-508. PubMed ID: 23374074
[TBL] [Abstract][Full Text] [Related]
14. DJ-1, a Parkinson's disease related protein, aggregates under denaturing conditions and co-aggregates with α-synuclein through hydrophobic interaction.
Zhu M; H Patel S; Han S
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1759-1769. PubMed ID: 28330770
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Kinetics, Toxicity, Oligomer Formation, and Membrane Binding Capacity of α-Synuclein Familial Mutations at the A53 Site, Including the Newly Discovered A53V Mutation.
Mohite GM; Kumar R; Panigrahi R; Navalkar A; Singh N; Datta D; Mehra S; Ray S; Gadhe LG; Das S; Singh N; Chatterjee D; Kumar A; Maji SK
Biochemistry; 2018 Sep; 57(35):5183-5187. PubMed ID: 29771508
[TBL] [Abstract][Full Text] [Related]
16. Strategies to increase the reproducibility of protein fibrillization in plate reader assays.
Giehm L; Otzen DE
Anal Biochem; 2010 May; 400(2):270-81. PubMed ID: 20149780
[TBL] [Abstract][Full Text] [Related]
17. Temperature-dependent structural changes of Parkinson's alpha-synuclein reveal the role of pre-existing oligomers in alpha-synuclein fibrillization.
Ariesandi W; Chang CF; Chen TE; Chen YR
PLoS One; 2013; 8(1):e53487. PubMed ID: 23349712
[TBL] [Abstract][Full Text] [Related]
18. Co-existence of two different α-synuclein oligomers with different core structures determined by hydrogen/deuterium exchange mass spectrometry.
Paslawski W; Mysling S; Thomsen K; Jørgensen TJ; Otzen DE
Angew Chem Int Ed Engl; 2014 Jul; 53(29):7560-3. PubMed ID: 24740651
[TBL] [Abstract][Full Text] [Related]
19. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
[TBL] [Abstract][Full Text] [Related]
20. α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities.
Alam P; Bousset L; Melki R; Otzen DE
J Neurochem; 2019 Sep; 150(5):522-534. PubMed ID: 31254394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]